(Q27851678)
Statements
1 reference
First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors (English)
1 reference
10 December 2011
0 references
29
0 references
35
0 references
4688-95
0 references